Astrazeneca Products
March 15, 2025
AstraZeneca Looks to Cancer, RSV Drugs for Growth as Covid-Vaccine Demand Wanes - WSJ AstraZeneca says sales rose 10% in 2020, sees revenue growth ahead AstraZeneca Cancer Drug Imjudo Gets First Japan Approval (LON:AZN) - Bloomberg AstraZeneca weighs seeking full, not emergency, U.S. approval for COVID-19 shot - WSJ | Reuters | Astrazeneca Products